Defiance Silver Corp. (
CVE:DEF -
Get Free Report) shares were down 14.9% during mid-day trading on Friday . The company traded as low as C$0.19 and last traded at C$0.20. Approximately 3,690,396 shares traded hands during trading, an increase of 323% from the average daily volume of 871,438 shares. The stock had previously closed at C$0.24.
Defiance Silver Trading Down 14.9%
The firm has a market cap of C$70.50 million, a P/E ratio of -10.00 and a beta of 1.11. The business has a 50-day moving average price of C$0.22 and a 200-day moving average price of C$0.24.
About Defiance Silver
(
Get Free Report)
Defiance Silver Corp., an exploration stage company, acquires, explores, evaluates, and develops mineral properties primarily in Mexico. It primarily explores for gold, copper, and silver deposits. The company was formerly known as Defiance Capital Corp. and changed its name to Defiance Silver Corp. in June 2011.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Defiance Silver, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Defiance Silver wasn't on the list.
While Defiance Silver currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.